The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with Hepatitis C and HIV coinfection

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 4, 2015, Pages 456-462

  Kramer, Jennifer R ^a,b   Kowalkowski, Marc A ^a,b   Duan, Zhigang ^a,b   Chiao, Elizabeth Y ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

coinfection; hepatitis C virus; hepatocellular carcinoma; HIV related immune suppression

Indexed keywords

ADULT; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; VETERAN; VIRUS LOAD; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS C; COHORT ANALYSIS; COMPLICATION; LIVER NEOPLASMS; MIDDLE AGED;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COINFECTION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; VETERANS;

EID: 84924523839     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000494     Document Type: Conference Paper

References (21)

1. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a crosssectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837
2. Sulkowski MS, Mast EE, Seeff LB, et al. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000;30(suppl 1):77-84
3. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993; 18:47-53
4. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease [see comments]. N Engl J Med. 1993;328:1797-1801
5. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a metaanalysis. Clin Infect Dis. 2001;33:562-569
6. Berretta M, Garlassi E, Cacopardo B, et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist. 2011;16: 1258-1269
7. Bourcier V, Winnock M, Ait AM, et al. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol. 2012;36:214-221
8. Kramer JR, Giordano TP, Richardson P, et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. Am J Gastroenterol. 2005;100:56-63
9. Clifford GM, Rickenbach M, Polesel J, et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS. 2008; 22:2135-2141
10. Bruyand M, Dabis F, Vandenhende MA, et al. HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008. J Hepatol. 2011;55: 1058-1062
11. Ioannou GN, Bryson CL, Weiss NS, et al. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology. 2013;57:249-257
12. Backus L, Mole L, Chang S, et al. The Immunology Case Registry. J Clin Epidemiol. 2001;54(suppl 1):12-15
13. Backus LI, Gavrilov S, Loomis TP, et al. Clinical Case Registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc. 2009;16:775-783
14. Davila JA, Weston A, Smalley W, et al. Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2007;41:777-782
15. Kowalkowski MA, Mims MP, Amiran ES, et al. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma. PLoS One. 2013;8:e77409
16. Chiao EY, Hartman CM, El-Serag HB, et al. The impact of HIV viral control on the incidence of HIV-Associated anal cancer. J Acquir Immune Defic Syndr. 2013;63:631-638
17. Backus LI, Boothroyd DB, Phillips BR, et al. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol. 2011;9:509-516
18. Kramer JR, Kanwal F, Richardson P, et al. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012; 56:320-325
19. Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-To-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-Analysis. Hepatology. 2011;53: 726-736
20. Lo RV III, Kallan MJ, Tate JP, et al. Hepatic decompensation in antiretroviral-Treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med. 2014;160:369-379
21. Kabali C, Cheng DM, Brooks DR, et al. Recent cigarette smoking and HIV disease progression: no evidence of an association. AIDS Care. 2011;23:947-956